VivaZome to collaborate with UQ Traumatic Brain Injury experts to develop exosome-based therapies
Posted: 20 May 2022 19th May 2022; Melbourne, Australia: VivaZome Therapeutics Pty Ltd (VivaZome) today announced that it has entered into a Memorandum of Understanding (MoU) with The University of Queensland (UQ) focussing on improved therapies for Traumatic…
ENA Respiratory Selected for BLUE KNIGHT™ to Accelerate Development of Pan-Antiviral Nasal Spray
Posted: 19 May 2022 Sydney, Australia, 11th May 2022 – ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-spectrum antiviral innate immunomodulator for pan-antiviral prophylaxis in at-risk populations and pandemic preparedness, has been selected to join…
The Power of Meaningful Relationships
Posted: 19 May 2022 The Connecting Women Lunch hosted on Friday 13th May 2022 marked its 12th anniversary. It was an honour to be back this year as a guest and see women celebrated for their achievements within…
$180m redevelopment of St Vincent’s Private Hospital Fitzroy set to begin
Posted: 19 May 2022 Construction set to begin on $180 million St Vincent’s Private Hospital Fitzroy redevelopment St Vincent’s Health Australia will mark the start of construction of its state-of-the-art, $180m Fitzroy private hospital redevelopment with a sod-turning…
Future Skills in Pharmaceutical GMP Supported by Updated Units of Competency
Posted: 9 May 2022 Skills in pharmaceutical good manufacturing practice (GMP) are essential to the Australian pharmaceutical industry, which support the production and distribution of safe and effective pharmaceuticals for the public. The skills for working in Pharmaceutical…
Bionics Institute Excellence in Medical Device Innovation Award – nominations close 13 May
Posted: 6 May 2022 Nominations close: 13 May 2022 Nominations for the Bionics Institute 2022 Award for Excellence in Medical Device Innovation close on Friday 13 May. This accolade recognises an Australian who, through innovation, has made a…
Awards Recognise Women Excellence in Healthtech
Posted: 5 May 2022 The innovation and inspiration of three outstanding women in Victoria’s healthtech industry have been recognised with BioMelbourne Network Women in Leadership Awards. Their work has helped spark industry advancement and inspire others to follow…
Tessara Therapeutics reinforces Advisory Board with the appointment of global industry leaders in 3D tissue models for drug discovery and cell therapies
Posted: 3 May 2022 Tessara Therapeutics, an Australian biotechnology company developing synthetic human brain micro-tissues as drug screening and neuro-regenerative medicine platforms, continues to ready itself for commercial entry with a series of high-profile Advisory Board appointments. Tessara…
Cancer Therapeutics CRC/Canthera Discovery win CRA Award for Research Commercialisation
Posted: 28 April 2022 Canthera Discovery is delighted to announce that its predecessor, Cancer Therapeutics CRC, received the Cooperative Research Australia (CRA) Excellence in Innovation Award for Research Commercialisation at an award ceremony at Parliament House in Canberra…
Presentation at the Lucust Walk Stem Cell Tx Conference
Posted: 8 April 2022 Event Date: 12 April 2022 Dr Ian Nisbet Chief Operating Officer Held in partnership with Harvard Stem Cell Institute, this virtual one-day investor and partner conference will explore stem cell therapeutics in the areas…
Cartherics CEO Alan Trounson ranked among the world’s most prominent scientists
Posted: 4 April 2022 The respected scientific platform Research.com has published the 2022 Edition of its Ranking of Top 1000 Scientists in the area of Biology and Biochemistry. BioMelbourne Network Member Cartherics welcomes the findings. In a notice…
2023 Australian Academy of Science Awards nominations closing soon
Posted: 4 April 2022 Nominations closing: 1 May 2022 Each year, the Australian Academy of Science shines a light on researchers who have made outstanding contributions to science, and in progressing the advancement of science in Australia, by…
